These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 18221984
21. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martín J, Gonzalez-Gay MA. J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870 [Abstract] [Full Text] [Related]
22. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. Uddhammar A, Eriksson AL, Nyström L, Stenling R, Rantapää-Dahlqvist S. J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015 [Abstract] [Full Text] [Related]
23. The role of unilateral temporal artery biopsy. Hall JK, Volpe NJ, Galetta SL, Liu GT, Syed NA, Balcer LJ. Ophthalmology; 2003 Mar; 110(3):543-8; discussion 548. PubMed ID: 12623818 [Abstract] [Full Text] [Related]
24. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. Liozon E, Boutros-Toni F, Ly K, Loustaud-Ratti V, Soria P, Vidal E. J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402 [Abstract] [Full Text] [Related]
25. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiardi L. Rheumatology (Oxford); 2009 Mar; 48(3):250-3. PubMed ID: 19109317 [Abstract] [Full Text] [Related]
26. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Zweegman S, Makkink B, Stehouwer CD. Neth J Med; 1993 Apr; 42(3-4):128-31. PubMed ID: 8316325 [Abstract] [Full Text] [Related]
27. Giant cell arteritis without clinically evident vascular involvement in a defined population. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Arthritis Rheum; 2004 Apr 15; 51(2):274-7. PubMed ID: 15077272 [Abstract] [Full Text] [Related]
28. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Semin Arthritis Rheum; 2001 Feb 15; 30(4):249-56. PubMed ID: 11182025 [Abstract] [Full Text] [Related]
29. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Danesh-Meyer H, Savino PJ, Gamble GG. Ophthalmology; 2005 Jun 15; 112(6):1098-103. PubMed ID: 15885780 [Abstract] [Full Text] [Related]
30. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults. Azhar SS, Tang RA, Dorotheo EU. Geriatrics; 2005 Aug 15; 60(8):26-30. PubMed ID: 16092890 [Abstract] [Full Text] [Related]
31. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis. Jakobsson K, Jacobsson L, Mohammad AJ, Nilsson JÅ, Warrington K, Matteson EL, Turesson C. BMC Musculoskelet Disord; 2016 Aug 24; 17(1):363. PubMed ID: 27558589 [Abstract] [Full Text] [Related]
32. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis. Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, Bellafiore S, Cimino L, Salvarani C. J Autoimmun; 2016 May 24; 69():94-101. PubMed ID: 27009904 [Abstract] [Full Text] [Related]
33. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. González-Gay MA, Blanco R, Abraira V, García-Porrúa C, Ibáñez D, García-Pais MJ, Rigueiro MT, Sánchez-Andrade A, Guerrero J, Casariego E. J Rheumatol; 1997 Nov 24; 24(11):2171-6. PubMed ID: 9375880 [Abstract] [Full Text] [Related]
34. New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study. Liozon E, Parreau S, Dumonteil S, Gondran G, Bezanahary H, Ly KH, Fauchais AL. Rheumatol Int; 2023 Jul 24; 43(7):1323-1331. PubMed ID: 37024620 [Abstract] [Full Text] [Related]
36. [Giant-cell arteritis: a descriptive study in southwestern Spain]. Calvo Romero JM, Magro Ledesma D, Ramos Salado JL, Bureo Dacal JC, de Dios Arrebola García J, Bureo Dacal P, Pérez Miranda M. An Med Interna; 2000 Feb 24; 17(2):67-70. PubMed ID: 10829459 [Abstract] [Full Text] [Related]
37. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Costello F, Zimmerman MB, Podhajsky PA, Hayreh SS. Eur J Ophthalmol; 2004 Feb 24; 14(3):245-57. PubMed ID: 15206651 [Abstract] [Full Text] [Related]
38. -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis. Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni PL, Cimino L, Bajocchi GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Boiardi L. Ann Rheum Dis; 2008 Apr 24; 67(4):485-8. PubMed ID: 17704068 [Abstract] [Full Text] [Related]
39. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Hayreh SS, Zimmerman B. Ophthalmology; 2003 Jun 24; 110(6):1204-15. PubMed ID: 12799248 [Abstract] [Full Text] [Related]
40. Statin therapy does not seem to benefit giant cell arteritis. Narváez J, Bernad B, Nolla JM, Valverde J. Semin Arthritis Rheum; 2007 Apr 24; 36(5):322-7. PubMed ID: 17204308 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]